Pregabalin-associated increase of clozapine serum levels.
Susanne
S
Englisch
Barbara
B
Alm
Andreas
A
Meyer-Lindenberg
Mathias
M
Zink
D018692:Antimanic Agents / Q000494:pharmacology*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D003024:Clozapine / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000494:pharmacology*; D008297:Male; D012559:Schizophrenia / Q000188:drug therapy*; D013469:Sulpiride / Q000031:analogs & derivatives*; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives*
D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D005680:gamma-Aminobutyric Acid; D013469:Sulpiride; D003024:Clozapine